↓ Skip to main content

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

Overview of attention for article published in Blood Cancer Journal, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
15 X users

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
116 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
Published in
Blood Cancer Journal, January 2019
DOI 10.1038/s41408-019-0170-3
Pubmed ID
Authors

Musa Yilmaz, Feng Wang, Sanam Loghavi, Carlos Bueso-Ramos, Curtis Gumbs, Latasha Little, Xingzhi Song, Jianhua Zhang, Tapan Kadia, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Nicholas Short, Guillermo Garcia-Manero, Zeev Estrov, Hagop Kantarjian, Andrew Futreal, Koichi Takahashi, Farhad Ravandi

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 116 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 16%
Student > Bachelor 18 16%
Student > Master 15 13%
Researcher 10 9%
Other 7 6%
Other 10 9%
Unknown 38 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 32 28%
Medicine and Dentistry 20 17%
Immunology and Microbiology 6 5%
Engineering 6 5%
Agricultural and Biological Sciences 5 4%
Other 9 8%
Unknown 38 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2022.
All research outputs
#1,338,072
of 25,362,278 outputs
Outputs from Blood Cancer Journal
#130
of 1,275 outputs
Outputs of similar age
#31,388
of 446,830 outputs
Outputs of similar age from Blood Cancer Journal
#4
of 27 outputs
Altmetric has tracked 25,362,278 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,275 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,830 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.